These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma. Xu J; Kadariya Y; Cheung M; Pei J; Talarchek J; Sementino E; Tan Y; Menges CW; Cai KQ; Litwin S; Peng H; Karar J; Rauscher FJ; Testa JR Cancer Res; 2014 Aug; 74(16):4388-97. PubMed ID: 24928783 [TBL] [Abstract][Full Text] [Related]
5. A mouse model recapitulating molecular features of human mesothelioma. Altomare DA; Vaslet CA; Skele KL; De Rienzo A; Devarajan K; Jhanwar SC; McClatchey AI; Kane AB; Testa JR Cancer Res; 2005 Sep; 65(18):8090-5. PubMed ID: 16166281 [TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. Menges CW; Kadariya Y; Altomare D; Talarchek J; Neumann-Domer E; Wu Y; Xiao GH; Shapiro IM; Kolev VN; Pachter JA; Klein-Szanto AJ; Testa JR Cancer Res; 2014 Feb; 74(4):1261-1271. PubMed ID: 24371224 [TBL] [Abstract][Full Text] [Related]
7. Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma. Lecomte C; Andujar P; Renier A; Kheuang L; Abramowski V; Mellottee L; Fleury-Feith J; Zucman-Rossi J; Giovannini M; Jaurand MC Cell Cycle; 2005 Dec; 4(12):1862-9. PubMed ID: 16319530 [TBL] [Abstract][Full Text] [Related]
8. An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation. Cheung M; Kadariya Y; Pei J; Talarchek J; Facciolo F; Visca P; Righi L; Cozzi I; Testa JR; Ascoli V Cancer Genet; 2015 Oct; 208(10):502-7. PubMed ID: 26364129 [TBL] [Abstract][Full Text] [Related]
9. Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing. Mäki-Nevala S; Sarhadi VK; Knuuttila A; Scheinin I; Ellonen P; Lagström S; Rönty M; Kettunen E; Husgafvel-Pursiainen K; Wolff H; Knuutila S Lung; 2016 Feb; 194(1):125-35. PubMed ID: 26463840 [TBL] [Abstract][Full Text] [Related]
10. Inactivation of Kukuyan AM; Sementino E; Kadariya Y; Menges CW; Cheung M; Tan Y; Cai KQ; Slifker MJ; Peri S; Klein-Szanto AJ; Rauscher FJ; Testa JR Cancer Res; 2019 Aug; 79(16):4113-4123. PubMed ID: 31151962 [TBL] [Abstract][Full Text] [Related]
11. Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration. Borczuk AC; Pei J; Taub RN; Levy B; Nahum O; Chen J; Chen K; Testa JR Cancer Biol Ther; 2016; 17(3):328-35. PubMed ID: 26853494 [TBL] [Abstract][Full Text] [Related]
12. Long-Fiber Carbon Nanotubes Replicate Asbestos-Induced Mesothelioma with Disruption of the Tumor Suppressor Gene Cdkn2a (Ink4a/Arf). Chernova T; Murphy FA; Galavotti S; Sun XM; Powley IR; Grosso S; Schinwald A; Zacarias-Cabeza J; Dudek KM; Dinsdale D; Le Quesne J; Bennett J; Nakas A; Greaves P; Poland CA; Donaldson K; Bushell M; Willis AE; MacFarlane M Curr Biol; 2017 Nov; 27(21):3302-3314.e6. PubMed ID: 29112861 [TBL] [Abstract][Full Text] [Related]
13. CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure. Kettunen E; Savukoski S; Salmenkivi K; Böhling T; Vanhala E; Kuosma E; Anttila S; Wolff H BMC Cancer; 2019 May; 19(1):507. PubMed ID: 31138176 [TBL] [Abstract][Full Text] [Related]